Effects of Goshajinkigan (TJ-107) for oxaliplatin-induced peripheral neurotoxicity using the functional assessment of cancer therapy/gynecologic oncology group 12-item neurotoxicity questionnaire in a Phase II, multicenter, randomized, double-blind, placebo-controlled trial

Authors :: Aoyama, Toru
Morita, Satoshi
Kono, Toru
Hata, Taishi
Mishima, Hideyuki
Sakamoto, Junichi
Source :: Journal of Cancer Research and Therapeutics. Oct-Dec, 2021, Vol. 17 Issue 6, 1473
Publication Year :: 2021
Abstract: Byline: Toru. Aoyama, Satoshi. Morita, Toru. Kono, Taishi. Hata, Hideyuki. Mishima, Junichi. Sakamoto Background: The aim of the present study was to evaluate the efficacy of TJ-107 for oxaliplatin-induced peripheral [...]

Subjects :: Biological products -- Testing
Pharmacology, Experimental
Neuroprotective agents -- Testing
Neurotoxicity syndromes -- Care and treatment
Health

Tools